article thumbnail

Advancing Drug Development and Regulatory Compliance with AI-Enhanced Real-World Evidence

HIT Consultant

Sujay Jadhav, Verana Health CEO In recent years, regulatory bodies, such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have increasingly emphasized the use of real-world data (RWD) in clinical research and regulatory decisions, recognizing its potential to enhance drug development and improve patient outcomes.

article thumbnail

The Importance of the FDA Debarment List for Clinical Trials

Compliancy Group

Food and Drug Administration (FDA) holding them accountable. Researchers, vendors, and organizations who dont uphold these standards or use data that lacks integrity could face debarment from future clinical trials by the FDA. What Lands Someone on the FDA Debarment List for Clinical Trials?

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Brief Quantum Medicine Policy Guide

Bill of Health

These technologies can act as privacy enhancing techniques (PET) to ensure privacy and compliance with regulations like HIPAA and GDPR. US Legal Requirements for Quantum-Powered Medical Devices In the United States, some quantum-powered medical devices may be governed under the existing FDA regulatory framework.

FDA 182
article thumbnail

FDA and Digital Health Regulation

Health Blawg

The FDA had a digital health banner day on December 7, announcing one final guidance and two draft guidance documents (with a 60-day comment period). FDA has done a very good job of moving the ball forward, though there is certainly room for improvement, and there is opportunity for comment on two of the three guidance documents announced.

FDA 113
article thumbnail

FDA Cybersecurity Requirements for Medical Devices Now in Effect

HIPAA Journal

Food and Drug Administration (FDA) will not authorize their use. trillion omnibus spending bill – The Consolidated Appropriations Act, 2023 – took effect and the FDA now requires all regulatory submissions for medical devices to include information about the cybersecurity measures that have been implemented for the devices.

FDA 115
article thumbnail

Raising the Bar in Medical Device Compliance with Dot Compliance 

Dot Compliance

In the intricate landscape of medical device manufacturing, regulatory compliance is not just a checkbox—it’s a commitment to ensuring the highest quality and safety standards. At Dot Compliance, we understand the pivotal role of compliance, especially with the stringent requirements outlined in 21 CFR Part 820.

article thumbnail

FDA Drafts Public Health Emergency Transition Plan: What Device Manufacturers Need to Know

Healthcare Law Today

Food & Drug Administration (FDA) previously issued emergency use authorizations (EUA) and adopted emergency policies in response to the COVID-19 public health emergency (PHE) to facilitate the availability of key medical devices such as in vitro diagnostic tests, personal protective equipment, and ventilators.

FDA 98